AI-generated summary
This review discusses the treatment of bipolar disorder during the perinatal period, a time when women with the condition face increased risk of depressive recurrence and postpartum psychosis. The authors report that medication remains the mainstay of treatment, with choices made through a risk-benefit discussion with the physician, and that bright light therapy may be used for residual bipolar depressive symptoms as an alternative to medication augmentation.
- Who or what was studied
- Women with bipolar disorder during the perinatal period
- Limits stated in the abstract
- The abstract does not report any included studies, sample sizes, or the strength of the evidence supporting the recommendations.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.